ClinicalTrials.gg
CompletedNCT04266080Updated Nov 20, 2026

Game-Based Physical Activity in Childhood Cancer Survivors

An interventional study of Fitbit Inspire HR and Questionaires in Survivors of Childhood Cancer, sponsored by Memorial Sloan Kettering Cancer Center. Completed at 1 site in United States. Open to participants aged 10 Years to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Memorial Sloan Kettering Cancer Center · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 20, 2026Now CompletedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Not applicable
Ages
10 Years to 16 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 13 studies in Motor Activity by Memorial Sloan Kettering Cancer Center — 2 open to participants now, 6 under way, none of them phase 3. Motor Activity · Memorial Sloan Kettering Cancer Center.

Started
2020
with 1 other
No phase
6 of 13
none open now
Registered
9th of 13
by date

Among the 13 studies in Motor Activity by Memorial Sloan Kettering Cancer Center, this one is one of 2 that started in 2020, is one of 6 with no phase, and was the 9th registered.

Motor Activity

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

Browse Motor Activity studies →

Open to participants now

2 of the 13 studies in Motor Activity by Memorial Sloan Kettering Cancer Center are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 10 Years to 16 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Motor Activity by Memorial Sloan Kettering Cancer Center, or all of them as a file.
02

Study summary

This study will test whether a game-based exercise plan can help increase the level of physical activity in childhood cancer survivors. The game-based exercise plan will involve participation by both a childhood cancer survivor and his/her parent or caregiver. This study will also look at whether the game-based exercise plan improves childhood cancer survivors' quality of life.

03

Conditions studied

  • Survivors of Childhood Cancer

Browse trials for

Keywords

  • Game-Based
  • Physical Activity
  • 20-040
04

Who can participate

Ages eligible
10 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Childhood cancer survivor:

  • History of treatment for childhood cancer with cardiotoxic therapy (anthracyclines, chest radiation, total body irradiation)
  • Off all systemic cancer therapy for ≥ 2 years
  • Ability to speak and understand English
  • Ability to complete all protocol assessments
  • Mobile device with SMS text messaging capability
  • Ambulatory and able to perform all study requirements
  • Attained age 10-16 years
  • Has a parent or legal guardian willing to participate in the study as a dyad
  • Willing to receive daily SMS text message alerts
  • Not currently exercising at least 30 minutes per day (5 days/week)
  • Performance Status of 0-1

Parent/legal guardian:

  • Parent or legal guardian of a childhood cancer survivor treated with cardiotoxic therapy (anthracyclines, chest radiation, total body irradiation)
  • Parent or legal guardian of a child age 10-16 years who is at least 2 years from completion of systemic cancer therapy
  • Ability to speak and understand English
  • Ability to complete all protocol assessments
  • Ability to provide
  • Ambulatory and able to perform all study requirements
  • Access to a mobile device with SMS text messaging capability
  • Is the parent or legal guardian of a childhood cancer survivor who is willing to participate in this study as a dyad
  • Willing to receive daily SMS text message alerts
  • ECOG Performance Status of 0-1

Exclusion criteria

Exclusion Criteria:

  • Survivors, or parents/legal guardians of survivors, with a medical condition that makes it unsafe to complete study requirements are not eligible for this study. This includes a diagnosis of:

    • Severe persistent asthma
    • Known symptomatic coronary artery disease
    • Musculoskeletal defects that interfere with sustained physical activity
    • Any medical or psychosocial condition that, in the opinion of the investigator, would jeopardize the health of the participant during study procedures
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ECOG performance status

A scale of how much an illness limits everyday activity. For people being assessed to join a study, scores run from 0 (fully active) to 4; lower is more active.

0
Fully active, no restrictions.
1
Limited in strenuous activity, but walking and able to do light work, such as housework or office work.
2
Walking and able to look after yourself, but unable to work; up and about more than half of waking hours.
3
Able to look after yourself only in part; in bed or a chair more than half of waking hours.
4
Unable to look after yourself at all; in bed or a chair all day.

Studies most often ask for 0–1 or 0–2. Your doctor gives the score; the WHO scale uses the same steps. The full scale also has 5, which records death.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
48 participants (actual)

Study arms

  • Experimental
    childhood cancer survivors & and one parent/legal guardian

    The study plans to recruit 30 childhood cancer survivors and a parent/legal guardian for each survivor. Participants will be provided with a Fitbit Inspire HR wearable device to record their step counts for two weeks pre-intervention, and over the six-month follow-up period (3-month intervention and 3month follow-up).

    Other: Fitbit Inspire HR · Other: Questionaires

Interventions

  • OtherFitbit Inspire HR

    assessing step counts

  • OtherQuestionaires

    Patient-Reported Outcomes Measurement Information System (PROMIS)

06

What researchers measure

Primary outcomes

  1. Acceptability of the intervention

    (i.e., all four responses on the AIM rates as either a 4 or 5 on a 5-point Likert scale of acceptability);

    Time frame: 3 months

Secondary outcomes

  1. step count

    step count by FitBit-type devices

    Time frame: 3 months

  2. hours of sleep per night

    by FitBit-type devices

    Time frame: 3 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2020 to primary completion in Nov 2026, 81 months.

Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's 81 months is above that.

Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 20, 2026: primary completion Feb 2027 → Nov 2026 and completion Feb 2027 → Nov 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2020
First posted
Feb 12, 2020
StartActual
Feb 7, 2020
Primary completionActual
Nov 17, 2026was Feb 2027
CompletionActual
Nov 17, 2026was Feb 2027
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Nov 20, 2026
Primary completion
Feb 2027→Nov 17, 2026 (actual)
Nov 20, 2026
Study completion
Feb 2027→Nov 17, 2026 (actual)
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    Active, not recruiting→Completed
    Primary completion Feb 2027→Nov 17, 2026 (now actual)
    Study completion Feb 2027→Nov 17, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04266080
Collaborators
Sohn Conference Foundation
Responsible party
Sponsor
First posted
Feb 12, 2020
Start date
Feb 7, 2020
Primary completion
Nov 17, 2026
Completion
Nov 17, 2026
Last update
Nov 20, 2026

Study contacts

Danielle Friedman, MD
principal investigator · Memorial Sloan Kettering Cancer Center

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion